Professor and chair of the Department of Obstetrics and Gynecology at the University of Ulm, Germany, where he undertakes research and is principal investigator in a number of clinical studies and was previously chair in Heinrich-Heine-University, Düsseldorf. He is specialized in gynecological oncology, with a focus on breast cancer. His research received numerous international awards, including those of ASCO, AACR and SABCS. 

Prof. Wolfgang Janni has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AstraZeneca, Cellgene, Chugai, Daiichi Sankyo, Eisai, Exact Science, Gilead, GSK, Guardant Health, Janssen, Lilly, Menarini Stemline, MSD, Neo Genomics, Novartis, Pfizer, Roche, Sanofi-Aventis and Seagen.